These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20977365)

  • 1. Bile acid sequestrants: glucose-lowering mechanisms.
    Prawitt J; Staels B
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S3-8. PubMed ID: 20977365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
    Fiorucci S; Mencarelli A; Palladino G; Cipriani S
    Trends Pharmacol Sci; 2009 Nov; 30(11):570-80. PubMed ID: 19758712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.
    Hansen M; Sonne DP; Knop FK
    Curr Diab Rep; 2014; 14(5):482. PubMed ID: 24623198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pathways for glycaemic control in type 2 diabetes: focus on bile acid modulation.
    Brinton EA
    Diabetes Obes Metab; 2008 Nov; 10(11):1004-11. PubMed ID: 18494807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.
    Sonne DP; Hansen M; Knop FK
    Eur J Endocrinol; 2014 Aug; 171(2):R47-65. PubMed ID: 24760535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway.
    Goldfine AB
    Curr Opin Cardiol; 2008 Sep; 23(5):502-11. PubMed ID: 18670263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids and signal transduction: role in glucose homeostasis.
    Nguyen A; Bouscarel B
    Cell Signal; 2008 Dec; 20(12):2180-97. PubMed ID: 18634871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids, farnesoid X receptor, atherosclerosis and metabolic control.
    Kuipers F; Stroeve JH; Caron S; Staels B
    Curr Opin Lipidol; 2007 Jun; 18(3):289-97. PubMed ID: 17495603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond intestinal soap--bile acids in metabolic control.
    Kuipers F; Bloks VW; Groen AK
    Nat Rev Endocrinol; 2014 Aug; 10(8):488-98. PubMed ID: 24821328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T; Staels B; Kuipers F
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
    Prawitt J; Caron S; Staels B
    Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.
    Spinelli V; Chávez-Talavera O; Tailleux A; Staels B
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):138-44. PubMed ID: 26859552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
    González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid sequestrants: more than simple resins.
    Out C; Groen AK; Brufau G
    Curr Opin Lipidol; 2012 Feb; 23(1):43-55. PubMed ID: 22186660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid sequestrants for lipid and glucose control.
    Staels B; Handelsman Y; Fonseca V
    Curr Diab Rep; 2010 Feb; 10(1):70-7. PubMed ID: 20425070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
    Tiwari A; Maiti P
    Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
    Kobayashi M; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Babaya N; Itoi-Babaya M; Yamaji K; Hiromine Y; Shibata M; Ogihara T
    Diabetes; 2007 Jan; 56(1):239-47. PubMed ID: 17192488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
    Levy P
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S9-13. PubMed ID: 20946010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
    Watanabe M; Houten SM; Mataki C; Christoffolete MA; Kim BW; Sato H; Messaddeq N; Harney JW; Ezaki O; Kodama T; Schoonjans K; Bianco AC; Auwerx J
    Nature; 2006 Jan; 439(7075):484-9. PubMed ID: 16400329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.